Phase II Study of Preoperative Intra-Arterial Epirubicin, Etoposide, and Oxaliplatin Combined with Oral S-1 Chemotherapy for the Treatment of Borrmann Type 4 Gastric Cancer

PURPOSE: A phase II study was conducted to evaluate the safety and efficacy of preoperative, intra-arterial perfusion of epirubicin, etoposide, and oxaliplatin combined with oral chemotherapy S-1 (SEEOX) for the treatment of type 4 gastric cancer. MATERIALS AND METHODS: A single-center, single-arm p...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiang, Xiao-song, Su, Yu, Li, Guo-li, Ma, Long, Zhou, Chang-sheng, Ma, Ru-feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Gastric Cancer Association 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781743/
https://www.ncbi.nlm.nih.gov/pubmed/33425441
http://dx.doi.org/10.5230/jgc.2020.20.e40

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781743/
https://www.ncbi.nlm.nih.gov/pubmed/33425441
http://dx.doi.org/10.5230/jgc.2020.20.e40

Ejemplares similares